MedTrace Logo

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

NCT00187512 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2025-07-08

No results posted yet for this study

Summary

SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical data. SCOPE specimens will be used to examine multiple questions involving virologic, immunologic, and host factors involved in HIV-1 infection, progression, non-progression, response to treatment, control of HIV-1 virus, and evolution of drug resistance.

Conditions

  • HIV Infections

Sponsors & Collaborators

Principal Investigators

  • Steven G. Deeks, M.D. · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-03-31
Primary Completion
2032-12-31
Completion
2033-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00187512 on ClinicalTrials.gov